Cutaneous Allodynia as a Prognostic Factor in the Treatment of Migraine with Botulinum Toxin

被引：0

作者：

Mathew, P. ^{[1
]}

Cutrer, F. M. ^{[1
]}

Garza, I. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

来源：

HEADACHE | 2010年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S32 / S33

页数：2

共 50 条

[1] Cutaneous Allodynia as a Prognostic Factor in the Treatment of Migraine with Botulinum Toxin
Mathew, Paul G.
Cutrer, Fred Michael
Garza, Ivan
NEUROLOGY, 2010, 74 (09) : A571 - A571
[2] Cutaneous allodynia in migraine patients as a predictive factor for effectiveness of botulinum toxin treatment
Relja, Maja
Miletic, Vladimir
NEUROLOGY, 2007, 68 (12) : A195 - A196
[3] Effects of botulinum toxin type a on cranial cutaneous allodynia in the prophylactic treatment of chronic migraine
Winner, P.
HEADACHE, 2007, 47 (05): : 791 - 791
[4] Predictive factor for effectiveness of botulinum toxin treatment in migraine
Miletic, V.
Relja, Maja
CEPHALALGIA, 2007, 27 (06) : 744 - 744
[5] Botulinum Toxin in Migraine Treatment
Aydinlar, Elif Ilgaz
Dikmen, Pinar Yalinay
Kocaman, Ayse Sagduyu
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2013, 50 : 36 - 40
[6] Botulinum toxin A in the treatment of migraine
Jost, W. H.
NERVENHEILKUNDE, 2013, 32 (12) : 939 - 941
[7] Botulinum toxin treatment in herpetic neuralgia and allodynia: possible phamacotherapeutic mechanisms of botulinum toxin
Seo, M-W
Lim, M-H
CEPHALALGIA, 2009, 29 : 50 - 50
[8] Botulinum toxin a for treatment of chronic migraine
Grazzi, L.
Usai, S.
CEPHALALGIA, 2015, 35 : 50 - 51
[9] Botulinum toxin type A for the treatment of migraine
Aurora, Sheena
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) : 1085 - 1095
[10] Botulinum toxin type A for the treatment of cephalic cutaneous allodynia in chronic migraine: A randomized, double-blinded, placebo-controlled pilot trial
Monteiro, L.
Hollanda, L.
Melo, A.
MOVEMENT DISORDERS, 2013, 28 : S425 - S425

← 1 2 3 4 5 →